Evaluation of Tuberculosis Control Strategy and Challenges in Indonesia After Pandemic COVID-19

Meutya Zahra Eriansyah; Anggraeni Dian Ciptaningrum; Afifah Thaliah Putri Priyono; Almeria Annisa Putri; Riswandy Wasir

doi:10.55606/ijhs.v5i2.5091

Authors

Meutya Zahra Eriansyah Universitas Pembangunan Nasional “Veteran” Jakarta
Anggraeni Dian Ciptaningrum Universitas Pembangunan Nasional “Veteran” Jakarta
Afifah Thaliah Putri Priyono Universitas Pembangunan Nasional “Veteran” Jakarta
Almeria Annisa Putri Universitas Pembangunan Nasional “Veteran” Jakarta
Riswandy Wasir Universitas Pembangunan Nasional “Veteran” Jakarta

DOI:

https://doi.org/10.55606/ijhs.v5i2.5091

Keywords:

Tuberculosis, Strategy, Challenges, Pandemic COVID-19, Indonesia

Abstract

Prior to the COVID-19 pandemic, Indonesia had made measured progress in addressing its tuberculosis (TB) burden through national strategies such as DOTS and integration into the universal health coverage (UHC) system. However, the pandemic caused substantial disruption to TB control efforts, including declines in case detection, treatment coverage, and continuity of care. This literature review analyzed eight peer-reviewed articles published between 2020 and 2025, selected from the Google Scholar database, to assess post-pandemic TB control strategies and challenges in Indonesia. The findings indicate that digital platforms were increasingly utilized for TB screening, monitoring, and reporting, while community-based education and expanded partnerships with private providers were promoted to maintain service continuity. Despite these adaptations, challenges such as limited infrastructure, inadequate digital literacy, constrained resources, and persistent stigma remain significant barriers. Strengthening the health system’s capacity, improving policy coherence between TB programs and insurance schemes, and sustaining innovation through multisectoral collaboration are essential to rebuilding TB services and advancing toward national and global TB elimination goals.

Downloads

Download data is not yet available.

References

[1] T. Lestari et al., “Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014–2021,” PLOS Glob. Public Heal., vol. 2, no. 10 October, pp. 1–19, 2022, doi: 10.1371/journal.pgph.0001114.

[2] Y. A. Mashuri et al., “‘ I pity the TB patient ’: a mixed methods study assessing the impact of the 19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future,” BMJ Glob. Heal., vol. 9, pp. 1–10, 2024, doi: 10.1136/bmjgh-2023-014943.

[3] H. Surendra et al., “Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data,” Lancet Glob. Heal., vol. 11, no. 9, pp. e1412–e1421, 2023, doi: 10.1016/S2214-109X(23)00312-1.

[4] G. J. Caren, D. Iskandar, D. A. E. Pitaloka, R. Abdulah, and A. A. Suwantika, “COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia,” J. Multidiscip. Healthc., vol. 15, no. January, pp. 175–183, 2022, doi: 10.2147/JMDH.S341130.

[5] A. A. Malik et al., “Tuberculosis control and care in the era of COVID-19,” Health Policy Plan., vol. 35, no. 8, pp. 1130–1132, Oct. 2020, doi: 10.1093/heapol/czaa109.

[6] N. A. Vasquez, C. Oga-Omenka, V. Yellappa, B. W. Lestari, and A. Sassi, “COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria,” J. Clin. Tuberc. Other Mycobact. Dis., vol. 38, no. December 2024, p. 100503, 2025, doi: 10.1016/j.jctube.2024.100503.

[7] W. Winardi, H. Wahyuni, M. Hidayat, and A. Wirawan, “Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective,” Narra J, vol. 2019, no. December 2019, pp. 4–9, 2022, doi: doi.org/10.52225/narra.v2i2.80.

[8] B. W. Lestari et al., “Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia,” Lancet Reg. Heal. - West. Pacific, vol. 5, p. 100059, Dec. 2020, doi: 10.1016/j.lanwpc.2020.100059.

[9] D. K. Sunjaya, C. Paskaria, D. M. D. Herawati, M. Pramayanti, R. Riani, and I. Parwati, “Initiating a district-based public–private mix to overcome tuberculosis missing cases in Indonesia: readiness to engage,” BMC Health Serv. Res., vol. 22, no. 1, p. 110, Dec. 2022, doi: 10.1186/s12913-022-07506-4.

[10] W. Jiang et al., “Policy gaps in addressing market failures and intervention misalignments in tuberculosis control: prospects for improvement in China, India, and Indonesia,” Lancet Reg. Heal. - West. Pacific, vol. 46, p. 101045, May 2024, doi: 10.1016/j.lanwpc.2024.101045.

[11] Y. Kurniawan, M. D. Hartanti, and J. Suyanto, “Obstacles and prospects in a holistic approach to tuberculosis eradication : A systematic review,” Malahayati Int. J. Nurs. Heal. Sci., vol. 07, no. 9, pp. 1110–1122, 2024.

[12] L. J. Brubacher et al., “Health and tuberculosis systems resilience , the role of the private sector and pandemic preparedness : insights from a cross- country qualitative study with policymakers in India , Indonesia and Nigeria,” BMJ Glob. Heal., vol. 10, pp. 1–10, 2025, doi: 10.1136/bmjgh-2024-016180.

[13] G. Marme, J. Kuzma, P.-A. Zimmerman, N. Harris, and S. Rutherford, “Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea,” J. Public Health (Bangkok)., vol. 46, no. 2, pp. 267–276, May 2024, doi: 10.1093/pubmed/fdae018.

[14] F. Makbul and D. Amir, “Incidence of Tuberculosis in Primary Health Care during the COVID-19 Pandemic: A Longitudinal Study and Perspective from Eastern Indonesia,” J. Epidemiol. Public Heal., vol. 9, no. 1, pp. 117–128, Jan. 2024, doi: 10.26911/jepublichealth.2024.09.01.11.

[15] L. P. L. Wulandari et al., “Delivering HIV and TB services amidst the COVID-19 pandemic in Indonesia: a qualitative study of challenges and mitigation strategies,” J. Glob. Heal. Reports, vol. 8, Jun. 2024, doi: 10.29392/001c.117620.